netFormulary Dorset NHS
The Dorset Formulary has been developed in associations with
NHS Dorset Clinical Commissioning Group
Dorset County Hospital NHS Foundation Trust
Dorset Healthcare University NHS Foundation Trust
Poole Hospital NHS Foundation Trust
Royal Bournemouth and Christchurch Hospitals NHS Foundation Trust
 
 Search
 Formulary Chapter 8: Malignant disease and immunosuppression - Full Section
Notes:

Updated in accordance with CDF and NICE guidance May 2018. For latest CDF list click here.

 Useful Links
Numbers in brackets indicate counts of (Formulary items, Non Formulary items)
08.01 Cytotoxic drugs (1,1)
Drugs for cytotoxic-induced side-effects (4,4)
08.01.01 Alkylating drugs (7,4)
08.01.02 Anthracyclines and other cytotoxic antibiotics (10,1)
08.01.03 Antimetabolites (16,4)
08.01.04 Vinca alkaloids and etoposide (4,3)
08.01.05 Other antineoplastic drugs (22,6)
Dacarbazine and Temozolomide (2,0)
Platinum compounds (3,0)
Protein kinase inhibitors (32,9)
Taxanes (4,0)
Topoisomerase I inhibitors (2,2)
Monoclonal antibodies (17,1)
08.02 Drugs affecting the immune response (0,0)
Immunosuppressant therapy (0,0)
08.02.01 Antiproliferative immunosuppressants (3,0)
08.02.02 Corticosteroids and other immunosuppressants (5,1)
08.02.03 Anti-lymphocyte monoclonal antibodies (6,1)
08.02.04 Other immunomodulating drugs (5,1)
Multiple Sclerosis (9,1)
BCG bladder instillation (2,0)
Lenalidomide, pomalidomide, and thalidomide (3,0)
08.03 Sex hormones and hormone antagonists in malignant disease (0,0)
08.03.01 Oestrogens (2,0)
08.03.02 Progestogens (3,0)
08.03.03 Androgens (0,0)
08.03.04 Hormone antagonists (0,0)
08.03.04.01 Breast cancer (4,2)
08.03.04.02 Prostate cancer and gonadorelin analogues (0,0)
Gonadorelin analogues (4,1)
Anti-androgens (5,1)
Gonadotrophin-releasing hormone antagonists (1,0)
Radiopharmaceuticals (0,0)
08.03.04.03 Somatostatin analogues (3,1)
netFormulary